Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A review of neurotoxicities associated with immunotherapy and a framework for evaluation. | Neurooncol Adv | 2021 | 34859238 | PubTator, text mining | PubMed |
| Amino acid sequence homology between thyroid autoantigens and central nervous system proteins: Implications for the steroid-responsive encephalopathy associated with autoimmune thyroiditis. | J Clin Transl Endocrinol | 2021 | 34849350 | PubTator, text mining | PubMed |
| Tacrolimus as Single-Agent Immunotherapy and Minimal Manifestation Status in Nonthymoma Myasthenia Gravis. | J Immunol Res | 2021 | 34845439 | PubTator, text mining | PubMed |
| Novelties in Sport Sciences : Novi Sad, Serbia. 11 September 2021. | BMC Proc | 2021 | 34844590 | PubTator, text mining | PubMed |
| Assessment of Sarcopenia and Obesity in Patients with Myasthenia Gravis Using Dual-Energy X-ray Absorptiometry: A Cross-Sectional Study. | J Pers Med | 2021 | 34834491 | PubTator, text mining | PubMed |
| Fetal Surveillance in Pregnancies with Myasthenia Gravis. | Medicina (Kaunas) | 2021 | 34833495 | PubTator, text mining | PubMed |
| RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing. | Cells | 2021 | 34831073 | PubTator, text mining | PubMed |
| Comparative Analysis of BIOCHIP Mosaic-Based Indirect Immunofluorescence with Enzyme-Linked Immunosorbent Assay for Diagnosing Myasthenia Gravis. | Diagnostics (Basel) | 2021 | 34829445 | PubTator, text mining | PubMed |
| Robotic thymectomy for myasthenia gravis surgical techniques and outcomes. | J Thorac Dis | 2021 | 34795970 | PubTator, text mining | PubMed |
| Identification of the regulatory role of lncRNA HCG18 in myasthenia gravis by integrated bioinformatics and experimental analyses. | J Transl Med | 2021 | 34794447 | PubTator, text mining | PubMed |
| Neuromuscular Development and Disease: Learning From in vitro and in vivo Models. | Front Cell Dev Biol | 2021 | 34778273 | PubTator, text mining | PubMed |
| Recent Trends in Biofabrication Technologies for Studying Skeletal Muscle Tissue-Related Diseases. | Front Bioeng Biotechnol | 2021 | 34778240 | PubTator, text mining | PubMed |
| Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy. | Neurotherapeutics | 2021 | 34766257 | PubTator, text mining | PubMed |
| Linoleic acid and the regulation of glucose homeostasis: A review of the evidence. | Prostaglandins Leukot Essent Fatty Acids | 2021 | 34763302 | PubTator, text mining | PubMed |
| Clinical features, treatment and prognosis of MuSK antibody-associated myasthenia gravis in Northwest China: a single-centre retrospective cohort study. | BMC Neurol | 2021 | 34732168 | PubTator, text mining | PubMed |
| Neuromuscular Complications of Targeted Anticancer Agents: Can Tyrosine Kinase Inhibitors Induce Myasthenia Gravis? Getting Answers From a Case Report up to a Systematic Review. | Front Oncol | 2021 | 34722270 | PubTator, text mining | PubMed |
| A Comparison of Clinical, Electro-Diagnostic, Laboratory, and Treatment Outcome Differences in a Cohort of HIV-Infected and HIV-Uninfected Patients With Myasthenia Gravis. | Front Neurol | 2021 | 34721269 | PubTator, text mining | PubMed |
| Effectiveness and Safety of Rituximab for Refractory Myasthenia Gravis: A Systematic Review and Single-Arm Meta-Analysis. | Front Neurol | 2021 | 34721267 | PubTator, text mining | PubMed |
| Extending greedy feature selection algorithms to multiple solutions. | Data Min Knowl Discov | 2021 | 34720675 | PubTator, text mining | PubMed |
| Development of the Myasthenia Gravis (MG) Symptoms PRO: a case study of a patient-centred outcome measure in rare disease. | Orphanet J Rare Dis | 2021 | 34717694 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=54